‘Bachelorette’ alum reveals doctors found ‘blueberry-size lesion’ in his brain
Joe Amabile, an alum of the Bachelor franchise, has announced he is facing an early stage brain tumor diagnosis.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Joe Amabile, known for his appearances on the Bachelor franchise and 'Bachelor in Paradise', has revealed he was diagnosed with an early stage brain tumor. According to coverage, doctors discovered a lesion the size of a blueberry in his brain.
Reports from People.com, Entertainment Weekly, and ABC News emphasize that Amabile will undergo surgery to address the tumor. Page Six and Bachelor Nation also provided coverage of the diagnosis.
Future developments will center on the scheduled brain surgery and Amabile's recovery process.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 15m ago.
Quick answers
What was the size of the lesion found in Joe Amabile's brain?
According to Page Six, doctors found a 'blueberry-size lesion'.
What is the stage of the tumor?
Coverage from multiple outlets, including Entertainment Weekly and People.com, describes it as an early stage brain tumor.
What is the next step in Joe Amabile's medical treatment?
Amabile will undergo brain surgery.
Coverage (5)
- Joe Amabile Reveals He Has an ‘Early Stage Brain Tumor’ and Will Need Brain Surgery Bachelor Nation · 11h ago
- ‘Bachelor’ star Joe Amabile reveals diagnosis with early stage brain tumor, will undergo surgery Entertainment Weekly · 11h ago
- ‘Bachelor’ Alum Joe Amabile Says He Was Diagnosed with Early Stage Brain Tumor People.com · 11h ago
- 'Bachelor in Paradise' star Joe Amabile says tumor was discovered in his brain ABC News - Breaking News, Latest News and Videos · 11h ago
- ‘Bachelorette’ alum reveals doctors found ‘blueberry-size lesion’ in his brain Page Six · 11h ago
Topics
Related trends
Common Hormonal Contraceptive Linked to Risk of Rare Brain Tumor
Reports and regulatory meetings are highlighting a potential link between a common hormonal contraceptive and rare brain tumors.